Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. As a result, the firm’s free cash will go towards paying debts rather than funding new ventures. Balance Sheet: Cash etc. ; Alexion Pharmaceuticals total assets for 2020 were $18.103B, a 3.18% increase from 2019. Fundamental company data and analyst estimates provided by FactSet. View all ALXN assets, cash, debt, liabilities, shareholder equity and investments. Source: Kantar Media, Total Current Assets FOR CALCULATION PURPOSES ONLY, Total Assets FOR CALCULATION PURPOSES ONLY, Inventories FOR CALCULATION PURPOSES ONLY, Cash & Short Term Investments FOR CALCULATION PURPOSES ONLY, Other Liabilities (excl. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Alexion Balance Sheet Analysis From 2010 to 2021. As of September 30, 2019, this was approximately $230 million; the actual amount will be determined as of the transaction close. All quotes are in local exchange time. Balanced, Large Cap, Style Neutral. Alexion Pharmaceuticals total assets for the quarter ending December 31, 2020 were $18.103B, a 3.18% increase year-over-year. the difference between assets and liabilities). ... Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare ... Agreement with Alexion ... On or. m. Working Capital. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. Alexion Pharmaceuticals (NASDAQ:ALXN) Income Statement, Balance Sheet and Cash Flow Statement This page was last updated on 2/9/2021 by MarketBeat.com Staff 30 … As part of the acquisition, Alexion will also be acquiring the cash currently on Achillion’s balance sheet. The balance sheet is a financial report that shows the assets of a business (i.e. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Enterprise Value £24.23bn . Get the detailed balance sheet for Alexion Pharmaceuticals, Inc. (ALXN). ALXN: Alexion Pharmaceuticals, Inc. balance sheet. FINANCIAL BRIEF:: For the fiscal year ended 31 December 2020, AlexionPharmaceuticals, Inc. revenues increased 22% to $6.07B. Find out the revenue, expenses and profit or loss over the last fiscal year. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. FMP. ALEXION PHARMACEUTICALS, INC. TABLE 5: CONDENSED CONSOLIDATED BALANCE SHEETS (in millions) (unaudited) December 31, December 31, 2019 2018. While Alexion Pharmaceuticals has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. International stock quotes are delayed as per exchange requirements. what it owns), the liabilities (i.e. Le cours de l'action ELECTRONIC ARTS EA sur Boursorama : historique de la cotation sur NASDAQ, graphique, actualités, consensus des analystes et informations boursières Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sales numbers and profit forecasts are only visible to DRUGANALYST subscribers. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. By using this site you agree to the The process by which an early-stage investigationaltherapy such as nedosiran Notably, its price target of $127 a share is more than 25% above the current price of Alexion. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Exch. Alexion Pharmaceuticals (NAS:ALXN) Financial Strength Explanation. Quarterly or annual. Netincome decreased 75% to $603.4M. Ten years of annual and quarterly balance sheets for Alexion Pharmaceuticals (ALXN). The company has generated free cash flow of $2.1 billion so far this year. Get the annual and quarterly balance sheet of Alexion Pharmaceuticals, Inc. (ALXN) including details of assets, liabilities and shareholders' equity. Login or use an access code to view numbers and analysis. Other Liabilities (excl. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Up to 10 years of financial statements. Check the Balance Sheet Data of Alexion Pharmaceuticals Inc , ALXN stock! Ea … Get the annual and quarterly balance sheets for Alexion Pharmaceuticals, Inc. (ALXN) including details of assets, liabilities and shareholders’ equity. Visit a quote page and your recently viewed tickers will be displayed here. Data may be intentionally delayed pursuant to supplier requirements. View as % YoY growth or as % of revenue. The actual amounts will be determined as of the transaction close. Get the detailed quarterly/annual income statement for Alexion Pharmaceuticals, Inc. (ALXN). View ALXN financial statements in full. Copyright © 2021 MarketWatch, Inc. All rights reserved. Have Watchlists? Deferred Income), Cumulative Translation Adjustment/Unrealized For. Shares in Alexion Pharmaceuticals Inc are currently priced at $153.53. what it owes to others), and equity (i.e. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Annual balance sheet by MarketWatch. Alexion Pharmaceuticals total assets from 2006 to 2020. The company has generated free cash flow of $2.1 billion so far this year. Cash and cash equivalents $ 2,685.5 $ 1,365.5 Marketable securities. Balance Sheet is a snapshot of the financial position of Alexion Pharm at a specified time, usually calculated after every quarter, six months, or one year. (v) the Company’s collaborations with Novo Nordisk A/S; Roche; Eli Lilly and Company; Alexion Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; and Alnylam Pharmaceuticals, Inc.; and (vi) the Company’s strategy,business plans and focus. Enquire about access to our database. m. Book Value ps. View as % YoY growth or as % of revenue. All rights reserved. The balance sheet is clearly the area to focus on when you are analysing debt. ; Alexion Pharmaceuticals total assets for 2020 were $18.103B, a 3.18% increase from 2019. Alexion Pharm Balance Sheet has two main parts: assets and liabilities. As part of the acquisition, Alexion will also be acquiring the cash currently on Achillion’s balance sheet. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. 1,243.2 922.3 Inventories. Intraday data delayed at least 15 minutes or per exchange requirements. Up to 10 years of financial statements. Alexion ended the third quarter with $2.3 billion cash and $3 billion total debt on its balance sheet. Stocks USA. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Companies with rank of 3 or less are likely in financial distress. 627.6 472.5 Prepaid expenses and other current assets (1) Get the annual and quarterly balance sheets for Alexion Pharmaceuticals, Inc. (ALXN) including details of assets, liabilities and shareholders’ equity. According to the last reported balance sheet, Alexion Pharmaceuticals had liabilities of US$943.8m due within 12 months, and liabilities of US$3.35b due beyond 12 months. The Alexion treasury team decided to use automation to capture changing FX exposures every day. Get the annual and quarterly balance sheets for ALEXION PHARMAC. … Alexion Pharmaceuticals total assets for the quarter ending December 31, 2020 were $18.103B, a 3.18% increase year-over-year. DL-,0001 (AXP.DE) including details of assets, liabilities and shareholders’ equity. Source: FactSet. Get the latest balance sheet from Zacks Investment Research. As of December 31, 2019, cash and short-term investments were approximately $430 million. Alexion relies on its growing Soliris/Ultomiris franchise for around 85% of total revenue but it isn't the only treatment with growing sales in the company's lineup. Alexion will fund this deal, which is targeted to close in the third quarter of 2020, with the cash on hand. The company, whose balance sheet was strained by over $22B in debt, is seeking a bridge loan in the amount of $17.5B to fund the transaction. Ten years of annual and quarterly balance sheets for Alexion Pharmaceuticals (ALXN). View all ALXN assets, cash, debt, liabilities, shareholder equity and investments. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Alexion will also be acquiring $215 million of cash on Portola’s balance sheet, net of debt. M ind th be of are on ac. Gain, Unrealized Gain/Loss Marketable Securities, Total Shareholders' Equity / Total Assets, One year after COVID-19 was declared a pandemic, is the U.S returning to normal? While Alexion Pharmaceuticals has net cash on its balance sheet, it’s still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Alexion Pharmaceuticals has the Financial Strength Rank of 7. Get the annual and quarterly balance sheet of Alexion Pharmaceuticals, Inc. (ALXN) including details of assets, liabilities and shareholders' equity. Alexion Pharmaceuticals Inc. annual balance sheet for ALXN company financials. what it owes to others), and equity (i.e. Subscriber Agreement & Terms of Use, Get the annual and quarterly balance sheets for Alexion Pharmaceuticals, Inc. (ALXN) including details of assets, liabilities and shareholders’ equity. m. Diluted Weighted Average Shares. Intraday Data provided by FACTSET and subject to terms of use. The Income Statement (earnings report) for Alexion Pharmaceuticals Inc. Find the company's financial performance, revenue, and more. Alexion Pharmaceuticals has 3,082 employees across 23 locations and $6.07 B in annual revenue in FY 2020. On the other hand, it had cash of US$1.67b and US$1.02b worth of receivables due within a year. Deferred Income), Additional Paid-In Capital/Capital Surplus, Cumulative Translation Adjustment/Unrealized For. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Consulte el balance de Alexion, que resume la posición fiscal de la compañía, incluyendo activos, pasivos y el valor accionarial de los últimos periodos. Historical and current end-of-day data provided by FACTSET. the difference between assets and liabilities). Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. m. Book Value. Total assets can be defined as the sum of all assets on a company's balance sheet. Detailed balance sheet for Alexion Pharmaceuticals stock (ALXN), including cash, debt, assets, liabilities, and book value. As part of the acquisition, Alexion will also be acquiring cash currently on Portola’s balance sheet, net of debt of approximately $215 million that will become due upon closing. Create a list of the investments you want to track. How Healthy Is Alexion Pharmaceuticals's Balance Sheet? Finanz AG, which comprise the balance sheet, income statement and notes for the year ended 31. Market Cap £24.55bn . Already a client? Get the latest balance sheet from Zacks Investment Research. The maximum rank is 10. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Connecting FiREapps to the … Alexion Pharmaceuticals has become aware of scams from individuals, organizations, and Internet sites claiming to represent Alexion in recruitment activities in return for disclosing financial information. Something went wrong while loading Watchlist. Many Americans say their finances will take years to recover, ‘A life-changing achievement’ — what the $1.9 trillion COVID bill means for families with kids, The most frequently asked questions by Robinhood traders reveal ‘new type of uninformed equity-market participant’, Idaho Republicans seek to defund attorney general who didn’t join Texas suit to invalidate Biden win over Trump, Your kids want to buy Roblox stock? Alexion will fund the transaction with cash on hand. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Log in to see them here or sign up to get started. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Alexion Pharmaceuticals Inc 's Quarterly Balance Sheets, ALXN as of Sep 30 2017 - CSIMarket In depth view into Alexion Pharmaceuticals Financial Strength explanation, calculation, historical data and more what it owns), the liabilities (i.e. Analysts covering Alexion Pharmaceuticals Inc currently have a consensus Earnings Per … Alexion Pharmaceuticals total assets from 2006 to 2020. Exch. The balance sheet is a financial report that shows the assets of a business (i.e. View all ALXN assets, cash, debt, liabilities, shareholder equity and investments. But ultimately the future profitability of the business will decide if Alexion Pharmaceuticals can strengthen its balance sheet over time. At that level they are trading at 13.13% discount to the analyst consensus target price of 0.00. Get the balance sheet for Alexion Pharmaceuticals Inc, which summarizes the company's financial position including assets, liabilities, and more. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. This browser is no longer supported at MarketWatch. Career opportunities are published only through Alexion’s official communication channels. Check Alexion Pharm financial statements over time to gain insight into future company performance. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity. Alexion Pharmaceuticals Inc. quarterly balance sheet for ALXN company financials. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. 64.0 198.3 Trade accounts receivable, net. Total assets can be defined as the sum of all assets on a company's balance sheet. Alexion Pharmaceuticals Inc. annual balance sheet for ALXN company financials. Gain, Unrealized Gain/Loss Marketable Securities, Total Shareholders' Equity / Total Assets, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Revenues reflect ULTOMIRISsegment increase from $338.9M to $1.08B, Strensiq segmentincrease of … View all ALXN assets, cash, debt, liabilities, shareholder equity and investments. Discounted Cash Flow Model Markets Education Developers FMP. Privacy Notice, and Stock Alexion Pharmaceuticals Inc Heed these warnings first, Under $1.9 trillion stimulus bill, jobless Americans who earned less than $150,000 last year will save an average of $1,000 in taxes, What to do if you already filed taxes but want to claim the $10,200 unemployment tax break. Alexion Pharmaceuticals (NASDAQ:ALXN) Income Statement, Balance Sheet and Cash Flow Statement This page was last updated on 2/9/2021 by MarketBeat.com Staff 30 … Get the detailed balance sheet for Alexion Pharmaceuticals, Inc. (ALXN). Alexion ended the third quarter with $2.3 billion cash and $3 billion total debt on its balance sheet. Alexion Pharmaceuticals Inc. quarterly balance sheet by MarketWatch. Op deze pagina staat de Balans voor Alexion Pharmaceuticals Inc, dat een overzicht toont van de financiële positie van het bedrijf inclusief activa, passiva en nog veel meer. Liabilities are the debts or obligations of Alexion Pharm and are divided into current liabilities and long term liabilities. m. Net Debt. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Financially, this merger piles a lot of debt onto AstraZeneca's already strained balance sheet. Annual balance sheet by MarketWatch. Copyright © FactSet Research Systems Inc. All rights reserved. Quarterly or annual. Alexion Pharmaceuticals Inc 's Quarterly Balance Sheets, ALXN as of Dec 31 2020 - CSIMarket ALXN $153.92-1.7 -1.1% 05/02/21 . For the best MarketWatch.com experience, please update to a modern browser. As part of the acquisition, Alexion will also be acquiring cash currently on Portola’s balance sheet, net of debt of approximately $215 million that will become due upon closing. Major Indexes Balance Sheet Data. So if you're focused on the future you can check out … Alexion Pharmaceuticals Inc Balance Sheet Statement. After evaluating the risk management technology landscape, the company chose to implement FiREapps. Alexion Pharmaceuticals Inc. There are currently no items in this Watchlist. It is inolved in Legal, accounting, book-keeping and auditing activities; tax consultancy; market research and public opinion polling; business and management consultancy Alexion Business Services Private Limited's Annual General Meeting (AGM) was last held on 30 September 2019 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2019. While Alexion Pharmaceuticals has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Balance Sheet (Annual) ALXN / Alexion Pharmaceuticals, Inc. Balance Sheet shows account balances for the company at points in time. Alexion Pharmaceuticals Inc 's Quarterly Balance Sheets, ALXN as of Dec 31 2020 - CSIMarket Alexion will fund the transaction with cash on hand. m. NFA. Alexion Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Alexion Pharmaceuticals Inc. quarterly balance sheet by MarketWatch. December 2015. Alexion Pharmaceuticals Inc. ALXN: Alexion Pharmaceuticals, Inc. balance sheet. The balance sheet is clearly the area to focus on when you are analysing debt. When Alexion decided to transition the Swiss treasury functions to the United States, the time was right to upgrade the balance sheet hedging process. ALXN Financial Strength as of today (February 19, 2021) is 7. Cookie Notice ().